Abiomed Profit Margin

The latest profit margin for ABMD is 24.84% as of September 2022. That compares with 15.32% in the prior-year period — up 62.1% year over year. That is above the Healthcare sector average of 21.34%. Investors often review this figure alongside Abiomed's historical trend and sector peers before judging valuation or financial health.

Over the past year, ABMD's profit margin moved from 15.32% to 24.84% — a 62.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Abiomed's valuation or profitability profile.

Against Healthcare companies, ABMD currently prints 24.84% for profit margin, while the sector average sits near 21.34%. That is roughly 16.4% above the sector mean. Large gaps often invite a closer look at Abiomed's growth, margins, and balance sheet.

Profit Margin shows how effectively Abiomed converts resources into returns. At 24.84%, ABMD may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 15.32% in the prior-year period — up 62.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ABMD's profit margin (24.84%), review year-over-year change from 15.32%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.